Skip to main content
Premium Trial:

Request an Annual Quote

Tijan to Lead HHMI, Game Joins Genetix from GE Healthcare, and More

NEW YORK (GenomeWeb News) - The Howard Hughes Medical Institute has named Robert Tijan to replace Thomas Cech as its president. In April 2009, Tijan will take over for Cech, who earlier this year announced his decision to leave his post to return to research and teaching at the University of Colorado at Boulder
 
Tijan was a post-doc researcher at Cold Spring Harbor Laboratory with James Watson, and he currently is director of the Berkeley Stem Cell Center and faculty director of the Li Ka Shing Center for Biomedical and Health Sciences.
 

 
Genetix has tapped Stephen Game to fill the new position of head of research and development, a job he will begin in November. Game currently is a technology manager of cellular science at GE Healthcare Life Sciences, where he is involved in strategic development and product portfolio management. He arrived at GE Healthcare when it purchased Amersham Biosciences, where Game was department director of cell biology.
 

 
Upstream Biosciences has appointed Michael Hayden to its scientific advisory board. Hayden has co-founded three companies including Xenon Pharmaceuticals, Aspreva Pharmaceuticals, and Neurovir. He is currently chief scientific officer at Xenon, chairman of the medical advisory board at Aspreva, and he is director of the Canadian Genetic Diseases Network.
 

 
Bio Nano Consulting has appointed Mike Fisher to be director of business development and to manage a new contract with the UK. Fisher recently was the British government’s North American advisor on life sciences for UK Trade and Investment. He founded the Northwest Genetics Knowledge Park and helped develop a biotech cluster in the northwest of England.
 

 
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.